CorMedix Inc (CRMD)

[mlkrborn]

UP a bit; Cormedix announces first sales of Neutrolin in the EU (CRMD 0.83 TODAY ) : Co announced that it has received approval to commence sales of its Neutrolin catheter lock solution in Germany from the Hessian District President. As previously disclosed, the Company has received orders from several dialysis centers and now has begun fulfilling these orders today. In conjunction with ongoing sales and marketing of Neutrolin in Germany, the Company's 2014 strategic plan includes expanding Neutrolin sales into other targeted EU countries and other markets. Additionally, CorMedix will pursue label expansion for Neutrolin beyond its primary indication of hemodialysis, oncology, ICU, total parenteral nutrition and peritoneal dialysis.